Kurt Kletter
Overview
Explore the profile of Kurt Kletter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wagner C, Simpson M, Zeitlinger M, Bauer M, Karch R, Abrahim A, et al.
Clin Pharmacokinet
. 2010 Dec;
50(2):111-20.
PMID: 21142292
Background And Objective: In microdose studies, the pharmacokinetic profile of a drug in blood after administration of a dose up to 100 μg is measured with sensitive analytical techniques, such...
12.
Kletter K, Kalhs P
Expert Rev Hematol
. 2010 Nov;
3(4):405-10.
PMID: 21083032
(18)F-deoxyglucose (FDG) positron emission tomography (PET) and more recently FDG PET/computed tomography (CT) has become an important tool in the management of patients with Hodgkin and non-Hodgkin lymphoma. It adds...
13.
Assem-Hilger E, Lanzenberger R, Savli M, Wadsak W, Mitterhauser M, Mien L, et al.
Epilepsy Behav
. 2010 Sep;
19(3):467-73.
PMID: 20850389
We performed positron emission tomography using [carbonyl-(11)C]WAY-100635, a serotonin 1A (5-HT(1A)) receptor antagonist, in 13 patients with temporal lobe epilepsy (TLE) and in 13 controls. 5-HT(1A) receptor distribution mapping allowed...
14.
Schuetz M, Schmid M, Potter R, Kommata S, Georg D, Lukic D, et al.
Acta Oncol
. 2010 Sep;
49(7):941-7.
PMID: 20831481
Background: The aim of this pilot study was to assess tumour hypoxia in patients with cervical cancer before, during and after combined radio-chemotherapy and Magnetic Resonance Imaging (MRI) guided brachytherapy...
15.
Lanzenberger R, Wadsak W, Spindelegger C, Mitterhauser M, Akimova E, Mien L, et al.
Int J Neuropsychopharmacol
. 2010 Jun;
13(9):1129-43.
PMID: 20519060
Dysregulation of the hypothalamic-pituitary-adrenocortical axis with deficient glucocorticoid feedback and alterations in the serotonergic system have been identified as biological correlates of mood disorders. Close examination of the interaction between...
16.
Haeusler D, Nics L, Mien L, Ungersboeck J, Lanzenberger R, Shanab K, et al.
Nucl Med Biol
. 2010 May;
37(4):421-6.
PMID: 20447552
Introduction: Recently, [(18)F]FE@SUPPY and [(18)F]FE@SUPPY:2 were introduced as the first positron emission tomography (PET) tracers for the adenosine A(3) receptor. Thus, aim of the present study was the metabolic characterization...
17.
Moser U, Wadsak W, Spindelegger C, Mitterhauser M, Mien L, Bieglmayer C, et al.
Neurosci Lett
. 2010 Apr;
476(3):161-5.
PMID: 20399839
Serotonin modulates the activity of the hypothalamic-pituitary-adrenal (HPA) axis particularly via the serotonin-1A receptor (5-HT(1A)). Therefore, the rationale of this positron emission tomography (PET) study was to investigate the influence...
18.
Bauer M, Karch R, Neumann F, Wagner C, Kletter K, Muller M, et al.
J Cereb Blood Flow Metab
. 2009 Dec;
30(3):510-5.
PMID: 20010957
We attempted to assess regional differences in cerebral P-glycoprotein (P-gp) function by performing paired positron emission tomography (PET) scans with the P-gp substrate (R)-[(11)C]verapamil in five healthy subjects before and...
19.
Wagner C, Bauer M, Karch R, Feurstein T, Kopp S, Chiba P, et al.
J Nucl Med
. 2009 Nov;
50(12):1954-61.
PMID: 19910428
Unlabelled: Tariquidar, a potent, nontoxic, third-generation P-glycoprotein (P-gp) inhibitor, is a possible reversal agent for central nervous system drug resistance. In animal studies, tariquidar has been shown to increase the...
20.
Bauer M, Karch R, Neumann F, Abrahim A, Wagner C, Kletter K, et al.
Eur J Clin Pharmacol
. 2009 Aug;
65(9):941-6.
PMID: 19655132
Purpose: The aim of this study was to assess the influence of age on the functional activity of the multidrug efflux transporter P-glycoprotein (P-gp) at the human blood-brain barrier. Methods:...